Research profile · Nootropics
Bromantane
Adamantane derivative (actoprotector)
Available as: 1g, 2g, 5g, 10g
Overview
An adamantane-based compound developed in Russia, where it is used under the name Ladasten.
Mechanism
Increases dopamine synthesis by upregulating tyrosine hydroxylase and aromatic L-amino acid decarboxylase, rather than acting as a classic stimulant.
Research highlights
- Studied in Russia for asthenia and fatigue.
- Classified as a doping substance by WADA.
Compound data
- Type
- Small molecule